LRP1 Shedding in Human Brain: Roles of ADAM10 and ADAM17

Overview

Journal Mol Neurodegener

Publisher Biomed Central

Specialties Molecular Biology
Neurology

Date 2009 Apr 18

PMID 19371428

Citations 58

Authors

Qiang Liu

Juan Zhang

Hien Tran

Marcel M Verbeek

Karina Reiss

Steven Estus

Guojun Bu

Affiliations

Soon will be listed here.

Abstract

Background: The low-density lipoprotein receptor-related protein 1 (LRP1) plays critical roles in lipid metabolism, cell survival, and the clearance of amyloid-beta (Abeta) peptide. Functional soluble LRP1 (sLRP1) has been detected in circulating human placenta; however, whether sLRP1 is also present in the central nervous system is unclear.

Results: Here we show that abundant sLRP1 capable of binding its ligands is present in human brain tissue and cerebral spinal fluid (CSF). Interestingly, the levels of sLRP1 in CSF are significantly increased in older individuals, suggesting that either LRP1 shedding is increased or sLRP1 clearance is decreased during aging. To examine potential effects of pathological ligands on LRP1 shedding, we treated MEF cells with Abeta peptide and found that LRP1 shedding was increased. ADAM10 and ADAM17 are key members of the ADAM family that process membrane-associated proteins including amyloid precursor protein and Notch. We found that LRP1 shedding was significantly decreased in MEF cells lacking ADAM10 and/or ADAM17. Furthermore, forced expression of ADAM10 increased LRP1 shedding, which was inhibited by ADAM-specific inhibitor TIMP-3.

Conclusion: Our results demonstrate that LRP1 is shed by ADAM10 and ADAM17 and functional sLRP1 is abundantly present in human brain and CSF. Dysregulated LRP1 shedding during aging could alter its function and may contribute to the pathogenesis of AD.

Citing Articles

ApoE Receptor-2 R952Q Variant in Macrophages Elevates Soluble LRP1 to Potentiate Hyperlipidemia and Accelerate Atherosclerosis in Mice.

Turkson V, Haller A, Jaeschke A, Hui D Arterioscler Thromb Vasc Biol. 2024; 45(1):37-48.

PMID: 39508104 PMC: 11668615. DOI: 10.1161/ATVBAHA.124.321748.

Amyloid-β in Alzheimer's disease: Structure, toxicity, distribution, treatment, and prospects.

Yu Y, Yu S, Battaglia G, Tian X Ibrain. 2024; 10(3):266-289.

PMID: 39346788 PMC: 11427815. DOI: 10.1002/ibra.12155.

Approaches for Increasing Cerebral Efflux of Amyloid-β in Experimental Systems.

Loeffler D J Alzheimers Dis. 2024; 100(2):379-411.

PMID: 38875041 PMC: 11307100. DOI: 10.3233/JAD-240212.

Review: Mechanisms of TIMP-3 accumulation and pathogenesis in Sorsby fundus dystrophy.

Betts J, Troeberg L Mol Vis. 2024; 30:74-91.

PMID: 38601018 PMC: 11006011.

Age-dependent changes on fractalkine forms and their contribution to neurodegenerative diseases.

Eugenin J, Eugenin-von Bernhardi L, von Bernhardi R Front Mol Neurosci. 2023; 16:1249320.

PMID: 37818457 PMC: 10561274. DOI: 10.3389/fnmol.2023.1249320.

References

Kang D, Pietrzik C, Baum L, Chevallier N, Merriam D, Kounnas M . Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway. J Clin Invest. 2000; 106(9):1159-66. PMC: 301422. DOI: 10.1172/JCI11013. View

Marschang P, Brich J, Weeber E, Sweatt J, Shelton J, Richardson J . Normal development and fertility of knockout mice lacking the tumor suppressor gene LRP1b suggest functional compensation by LRP1. Mol Cell Biol. 2004; 24(9):3782-93. PMC: 387731. DOI: 10.1128/MCB.24.9.3782-3793.2004. View

Herz J, Kowal R, Goldstein J, Brown M . Proteolytic processing of the 600 kd low density lipoprotein receptor-related protein (LRP) occurs in a trans-Golgi compartment. EMBO J. 1990; 9(6):1769-76. PMC: 551881. DOI: 10.1002/j.1460-2075.1990.tb08301.x. View

Corder E, Saunders A, Strittmatter W, Schmechel D, Gaskell P, Small G . Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993; 261(5123):921-3. DOI: 10.1126/science.8346443. View

Selkoe D, Kopan R . Notch and Presenilin: regulated intramembrane proteolysis links development and degeneration. Annu Rev Neurosci. 2003; 26:565-97. DOI: 10.1146/annurev.neuro.26.041002.131334. View

Bu G, Maksymovitch E, Schwartz A . Receptor-mediated endocytosis of tissue-type plasminogen activator by low density lipoprotein receptor-related protein on human hepatoma HepG2 cells. J Biol Chem. 1993; 268(17):13002-9. View

Hartmann D, De Strooper B, Serneels L, Craessaerts K, Herreman A, Annaert W . The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts. Hum Mol Genet. 2002; 11(21):2615-24. DOI: 10.1093/hmg/11.21.2615. View

Herz J, Bock H . Lipoprotein receptors in the nervous system. Annu Rev Biochem. 2002; 71:405-34. DOI: 10.1146/annurev.biochem.71.110601.135342. View

Li Y, Osaka H, Fitzgerald D, Schwartz A, Bu G . Dissection of receptor folding and ligand-binding property with functional minireceptors of LDL receptor-related protein. J Cell Sci. 2001; 114(Pt 5):899-908. DOI: 10.1242/jcs.114.5.899. View

10.

von Arnim C, Kinoshita A, Peltan I, Tangredi M, Herl L, Lee B . The low density lipoprotein receptor-related protein (LRP) is a novel beta-secretase (BACE1) substrate. J Biol Chem. 2005; 280(18):17777-85. DOI: 10.1074/jbc.M414248200. View

11.

Karan D, Lin F, Bryan M, Ringel J, Moniaux N, Lin M . Expression of ADAMs (a disintegrin and metalloproteases) and TIMP-3 (tissue inhibitor of metalloproteinase-3) in human prostatic adenocarcinomas. Int J Oncol. 2003; 23(5):1365-71. View

12.

Li Y, Chen J, Lu W, McCormick L, Wang J, Bu G . Mesd binds to mature LDL-receptor-related protein-6 and antagonizes ligand binding. J Cell Sci. 2005; 118(Pt 22):5305-14. DOI: 10.1242/jcs.02651. View

13.

Quinn K, Grimsley P, Dai Y, Tapner M, Chesterman C, Owensby D . Soluble low density lipoprotein receptor-related protein (LRP) circulates in human plasma. J Biol Chem. 1997; 272(38):23946-51. DOI: 10.1074/jbc.272.38.23946. View

14.

Hoe H, Cooper M, Burns M, Lewis P, van der Brug M, Chakraborty G . The metalloprotease inhibitor TIMP-3 regulates amyloid precursor protein and apolipoprotein E receptor proteolysis. J Neurosci. 2007; 27(40):10895-905. PMC: 6672812. DOI: 10.1523/JNEUROSCI.3135-07.2007. View

15.

Hardy J, Selkoe D . The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 2002; 297(5580):353-6. DOI: 10.1126/science.1072994. View

16.

Zheng H, Koo E . The amyloid precursor protein: beyond amyloid. Mol Neurodegener. 2006; 1:5. PMC: 1538601. DOI: 10.1186/1750-1326-1-5. View

17.

Lutz C, Nimpf J, Jenny M, Boecklinger K, Enzinger C, Utermann G . Evidence of functional modulation of the MEKK/JNK/cJun signaling cascade by the low density lipoprotein receptor-related protein (LRP). J Biol Chem. 2002; 277(45):43143-51. DOI: 10.1074/jbc.M204426200. View

18.

Rebeck G, Reiter J, Strickland D, Hyman B . Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron. 1993; 11(4):575-80. DOI: 10.1016/0896-6273(93)90070-8. View

19.

Bu G, Geuze H, Strous G, Schwartz A . 39 kDa receptor-associated protein is an ER resident protein and molecular chaperone for LDL receptor-related protein. EMBO J. 1995; 14(10):2269-80. PMC: 398334. DOI: 10.1002/j.1460-2075.1995.tb07221.x. View

20.

Deuss M, Reiss K, Hartmann D . Part-time alpha-secretases: the functional biology of ADAM 9, 10 and 17. Curr Alzheimer Res. 2008; 5(2):187-201. DOI: 10.2174/156720508783954686. View